Plant-Based Diet for Patients With Rheumatoid Arthritis
PLATE: Health Effects of Plant-Based Diet in Patients With Rheumatoid Arthritis
1 other identifier
interventional
180
1 country
2
Brief Summary
The goal of this clinical trial is to evaluate the effect of a plant-based diet (PBD) intervention in adults with Rheumatoid Arthritis (RA) on disease activity. The investigators hypothesize that if patients with RA follow a 100% PBD over a 16-week period it will lead to improvements in: \- Disease activity (measured by DAS28), including reduction in symptoms and overall improvements in health-related quality of life. The effects of the PBD will be compared to a habitual diet, that includes no dietary changes. Participants in the intervention group will:
- Receive weekly delivery of food boxes which include plant-based food items
- Receive a daily multivitamin supplement
- Receive continuous dietetic guidance
- Participate in a practical cooking class to get an introduction to a PBD
- Participate in three online supervisions throughout the intervention period Participants in the control group will follow the same plan for the project visits at the hospital but will be restricted to continue their habitual diet. Thus, not performing any dietary changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 18, 2026
March 1, 2026
3 years
November 18, 2025
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease activity measured by DAS28
The Disease Activity Score 28 (DAS28) is a composite index used to assess disease activity in patients with rheumatoid arthritis. The DAS28 is a quantification of tender and swollen joints within the hands, shoulders, elbows, wrists, and knees. These assessments, in conjunction with CRP values obtained from blood samples and the self-reported global Visual Analog Scale (VAS) score, will be incorporated into the computation of DAS28. The DAS28 ranges from 0 to 10, with higher scores indicating higher disease activity.
16 weeks
Secondary Outcomes (1)
Ultrasound - supportive of the primary outcome
16 weeks
Other Outcomes (18)
Inflammatory biomarkers
16 weeks
Cholesterol
16 weeks
Glucose
16 weeks
- +15 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
The intervention is a 100% plant-based diet, and a daily multivitamin supplement. Participants in the intervention group will receive weekly food delivery to their household. Moreover, they will participate in a practical cooking workshop with other participants of the intervention group. Furthermore, they will have three online supervisions with relevant project staff.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- DAS28 score ≤3.2, and without swollen joints
- RA diagnosis of minimum one year
- Stable pharmacological treatment for at least four months and with no planned change in treatment within eight weeks
You may not qualify if:
- Smokers
- Diabetes mellitus
- Pregnancy / planned pregnancy
- Prednisolone treatment
- DAS28 above 3.2
- Current dietary habits resembling intervention diet (e.g., PBD lifestyle)
- Food allergies and intolerances
- Unable to understand the informed consent and study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Bispebjerg and Frederiksberg Hospital, Center for Clinical Research and Prevention
Frederiksberg, Denmark
The Department of Rheumatology and Spine Diseases, Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet, Glostrup
Glostrup Municipality, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Project nurses
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD
Study Record Dates
First Submitted
November 18, 2025
First Posted
December 5, 2025
Study Start
December 15, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share